January 28, 2014 — BioLeonhardt, a Leonhardt Ventures company based in Los Angeles, unveiled its implantable stem cell ...
July 28, 2009 – Bioheart Inc. today said the FDA cleared a phase I clinical trial for MyoCell SDF-1 (Stromal Derived ...
July 8, 2009 – Bioheart Inc. said this week a panel discussion on myoblast (muscle stem cell) therapy between ...
February 3, 2009 - Bioheart Inc. has arranged with its Italian partner, Biomedica, for a complete grant-supported study ...
December 17, 2008 - Bioheart Inc. announced yesterday its plan to shift focus from several non-core technology platforms ...
August 4, 2008 - Bioheart Inc. said last week it entered into a letter of intent to acquire MEDICALGORITHMICS Ltd. and ...
July 11, 2008 - Bioheart Inc. this week said it secured worldwide, nonexclusive distribution rights to the Bioheart 3370 ...
Bioheart Inc. offers the Bioheart 3370 Heart Failure Monitor, an interactive and simple-to-use at-home device designed ...